Mastidoll-3 4 ml (2 doz)

Inactivated vaccine against subclinical and clinical mastitis infections.

Target species

Cattle

Pharmaceutical form

Emulsion for injection

Indications

A bacterial, oil-adjuvanted, inactivated mixed vaccine prepared for protection of cows and heifers against subclinical and clinical mastitis infections caused by Escherichia coli, Staphylococcus aureus and Mycoplasma bovis.

Composition

COMPOSITION: Each vaccine dose (2 ml) contains:

Inactivated Escherichia coli D5 antigen · ≥ 1/40 ELISA seropositive*

Inactivated Staphylococcus aureus antigen · ≥ 1/40 ELISA seropositive*

Inactivated Mycoplasma bovis antigen · ≥ 1/40 ELISA seropositive*

Oil adjuvant · 50% (w/w)

Formaldehyde · < 0.4% (v/v)

PSS (physiological saline) · up to 1 ml

*Minimum serum dilution that is ELISA seropositive in sera of vaccinated rabbits

Dosage and administration

Cows and heifers are vaccinated with 2 ml intramuscularly in the neck. Animals vaccinated for the first time receive two administrations 21 days apart, then should be vaccinated every 6 months. Heifers can be vaccinated 2 months before their first calving, and cows in every period.

Withdrawal period

The withdrawal period in food-producing animals is 0 days.

Presentation

The vaccine is packed in 2 ml (1 dose) and 4 ml (2 doses) 6R type I amber glass bottles, in 10 ml (5 doses), 20 ml (10 doses), 50 ml (25 doses) and 100 ml (50 doses) type II amber glass bottles, or in 20 ml (10 doses), 50 ml (25 doses) and 100 ml (50 doses) white plastic bottles. Glass and plastic bottles are closed with the same butyl stopper and aluminium cap and labelled.

Vaccine bottles: 2 ml (1 dose) and 4 ml (2 doses) bottles in cartons of 5 and 10; 10 ml (5 doses), 20 ml (10 doses), 50 ml (25 doses) and 100 ml (50 doses) glass and plastic bottles in single cartons. Not all pack sizes may be marketed.